Novakivskyy, V. 2017. PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION. Ukrainian Journal of Nephrology and Dialysis. 1(53) (Mar. 2017), 26-31. DOI:https://doi.org/10.31450/ukrjnd.1(53).2017.04.